Protect Your Family’s Future: CDKN2A Genetic Testing for Melanoma and Neural Tumour Risk
When cancer runs in your family, every mole and every headache can feel like a potential threat. That constant worry doesn’t have to be your reality. The CDKN2A genetic test provides the clarity and peace of mind you deserve, giving you the power to take proactive steps against inherited melanoma and neural system tumour risks.
Understanding Your CDKN2A Genetic Test
The CDKN2A gene acts as your body’s natural tumour suppressor – it’s the guardian that helps prevent uncontrolled cell growth. When this gene carries specific mutations, it can significantly increase your lifetime risk of developing melanoma (the most dangerous form of skin cancer) and various neural system tumours.
Our advanced Next-Generation Sequencing (NGS) technology examines your CDKN2A gene with exceptional accuracy, identifying even the smallest genetic variations that could impact your health. This isn’t just a test – it’s a comprehensive health assessment that could change your family’s medical future.
Who Should Consider This Genetic Test?
This test is particularly important if you or your family members experience:
- Multiple cases of melanoma across generations
- Early-onset melanoma (before age 50)
- Family history of neural system tumours or brain cancers
- Multiple primary melanomas in one individual
- Pancreatic cancer in the family alongside melanoma cases
- Unexplained neural symptoms with family cancer patterns
If you’ve ever wondered “why does cancer keep appearing in my family?” – this test provides the answers you need.
Why Early Detection Matters for Your Health
Knowing your genetic status transforms fear into action. A positive result means you can:
- Begin enhanced surveillance and early detection protocols
- Make informed lifestyle choices to reduce environmental risks
- Consider preventative measures with your healthcare team
- Alert family members who may also be at risk
- Access specialised care before symptoms develop
Early detection of melanoma dramatically improves treatment outcomes – with 5-year survival rates exceeding 99% when caught early.
Understanding Your Test Results
We understand that waiting for genetic results can be anxiety-provoking. Our process is designed to support you every step of the way:
- Pre-test Genetic Counselling: We’ll create your family pedigree and explain what to expect
- Clear Result Interpretation: Your results will be explained in plain language you can understand
- Personalised Guidance: We provide specific recommendations based on your genetic profile
- Ongoing Support: Our team remains available to answer questions about your results
Remember: A positive result doesn’t mean you’ll definitely develop cancer – it means you have valuable information to help prevent it.
Investment in Your Health – Transparent Pricing
| Service | Regular Price | Special Price | Savings |
|---|---|---|---|
| CDKN2A Genetic Test | ZAR 9,350 | ZAR 6,700 | ZAR 2,650 |
Consider this: The cost of advanced melanoma treatment can exceed ZAR 500,000. Your ZAR 6,700 investment could save not only money but potentially your life.
Why Trust Oracle Genomics?
- Nationwide Coverage: Available throughout South Africa including Johannesburg, Cape Town, Durban, and Pretoria
- Medical Expertise: Specialist oncologists and genetic counsellors oversee every test
- Advanced Technology: State-of-the-art NGS testing for maximum accuracy
- Multiple Sample Options: Blood, extracted DNA, or simple finger-prick blood spot
- Quick Turnaround: Results typically within 3-4 weeks
- Comprehensive Support: From initial counselling to result interpretation
Take Control of Your Genetic Health Today
Don’t let family cancer history dictate your future. With our special pricing of ZAR 6,700, there’s never been a better time to gain the knowledge that could protect your health for years to come.
Book your genetic counselling session now and start your journey toward proactive health management.
Available at our clinics nationwide – because your health shouldn’t wait.
